Dr Reddys Laboratories (RDY) Cost of Revenue (2009 - 2026)
Dr Reddys Laboratories (RDY) posted Cost of Revenue of $434.22 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 5.1% from $457.57 million a year earlier and down 4.8% from the prior quarter.
Dr Reddys Laboratories (RDY) Cost of Revenue (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Cost of Revenue at Dr Reddys Laboratories was $1.8 billion, up 3.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.69 billion, up 7.0% from FY2025.
- Annual Cost of Revenue has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 7.4% (FY2021 to FY2026).
- In prior fiscal years, Dr Reddys Laboratories' Cost of Revenue was $1.58 billion in FY2025 (+14.0%), $1.39 billion in FY2024 (+7.0%), $1.3 billion in FY2023 (-2.2%) and $1.33 billion in FY2022 (+11.8%).
- The fiscal Q2 2027 figure stands as the lowest quarterly Cost of Revenue since fiscal Q1 2026.
- On a year-over-year basis, Cost of Revenue increased in seven of the last eight quarters, with growth averaging 11.2%.
- The strongest year-over-year quarter for Cost of Revenue in the past five years was fiscal Q4 2025, with growth of 23.5%; the weakest was fiscal Q1 2023, with a decline of 13.8%.
- According to Business Quant data, Cost of Revenue for the three prior fiscal quarters was $455.94 million (Q1 2027), $453.66 million (Q4 2026) and $454.37 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,257.32 Bn | 1,230.94 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 680.81 Bn | 600.67 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 520.51 Bn | 488.52 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 366.45 Bn | 329.39 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 317.39 Bn | 290.63 Bn | - | - |
| 6 | Astrazeneca | 294.50 Bn | 268.39 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.76 Bn | 203.42 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 210.60 Bn | 185.71 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 168.24 Bn | 115.60 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Dr Reddys Laboratories | 12.54 Bn | 11.89 Bn | 472.93 Mn | 434.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 434.22 Mn |
| Jun 30, 2026 | 455.94 Mn |
| Mar 31, 2026 | 453.66 Mn |
| Dec 31, 2025 | 454.37 Mn |
| Sep 30, 2025 | 457.57 Mn |
| Jun 30, 2025 | 430.29 Mn |
| Mar 31, 2025 | 436.48 Mn |
| Dec 31, 2024 | 409.01 Mn |
| Sep 30, 2024 | 386.75 Mn |
| Jun 30, 2024 | 364.22 Mn |
| Mar 31, 2024 | 353.38 Mn |
| Dec 31, 2023 | 359.64 Mn |
| Sep 30, 2023 | 343.97 Mn |
| Jun 30, 2023 | 342.00 Mn |
| Mar 31, 2023 | 335.00 Mn |
| Dec 31, 2022 | 329.00 Mn |
| Sep 30, 2022 | 336.00 Mn |
| Jun 30, 2022 | 312.00 Mn |
| Mar 31, 2022 | 340.79 Mn |
| Dec 31, 2021 | 338.00 Mn |
Dr Reddys Laboratories Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();